Wang, X., Hu, C. S., Petersen, B., Qiu, J., Ye, F., Houldsworth, J., . . . Hoffman, R. (2018). Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells. Blood Adv.
Citação norma ChicagoWang, Xiaoli, Cing Siang Hu, Bruce Petersen, Jiajing Qiu, Fei Ye, Jane Houldsworth, Kevin Eng, Fei Huang, and Ronald Hoffman. "Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Stem and Progenitor Cells." Blood Adv 2018.
Citação norma MLAWang, Xiaoli, et al. "Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Stem and Progenitor Cells." Blood Adv 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.